References
Levey GS, Lasseter KC, Palmer RF. Sulfonylureas and the heart. Ann Rev Med 1974;25:69-74.
Lederer WJ, Nichols CG, Smith GL. The mechanism of early contractile failure of isolated rat ventricular myocytes subjected to complete metabolic inhibition. J Physiol 1989;413:329-349.
Eisner DA, Nichols CG, O'Neill SC, Smith GL, Valdeomillnos M. The effects of metabolic inhibition on intracellular calcium and pH in isolated rat ventricular cells. J Physiol 1989;411:393-418.
Gasser R, Vaughan-Jones RD. Mechanism of potassium efflux and action potential shortening during ischemia in isolated mammalian cardiac muscle. J Physiol 1990;431:713-741.
Procacci P, Zoppi M. Heart pain. In: eds PD Wall, R Melzack, Textbook of Pain. Edinburgh: Churchill Livingstone, 1983.
Cohn F. Possible mechanisms responsible for silent myocardial ischemia: Do patients with silent myocardial ischemia have altered pain thresholds? Cardiol Clin 1986;4:727-733.
Droste C, Greenlee MW, Roskamm H. A defective angina pectoris pain warning system: Experimental findings of ischemic and electrical pain test. Pain 1986;26:199-209.
Malliani A, Lombardi F. Circulatory markers of nervous activation during myocardial ischemia. Can J Cardiol 1986;12(Suppl A):40A-45A.
University Group Diabetes Program. A study of the effects of agents on vascular complications in patients with adult onset of diabetes. II. Mortality results. Diabetes 1970;19(Suppl 2):789-830.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gasser, R., Grisold, M., Pokan, R. et al. Blockade of ATP-Dependent K+ Channels in Myocardium and Coronary Artery Smooth Muscle: A Possible Cause of Increased Cardiovascular Mortality in Sulfonylurea-Treated Patients. Cardiovasc Drugs Ther 11, 87–89 (1997). https://doi.org/10.1023/A:1007768311189
Issue Date:
DOI: https://doi.org/10.1023/A:1007768311189